Liver damage profile in COVID-19 pregnant patients

被引:2
|
作者
Januszewski, Marcin [1 ]
Ziuzia-Januszewska, Laura [2 ]
Kudan, Michal [1 ]
Pluta, Kamil [1 ]
Klapaczynski, Jakub [3 ]
Wierzba, Waldemar [1 ]
Maciejewski, Tomasz [4 ]
Jakimiuk, Alicja A. [5 ]
Jakimiuk, Artur J. [1 ,6 ]
机构
[1] Minist Interior & Adm, Natl Med Inst, Dept Obstet & Gynecol, Woloska 137, PL-02507 Warsaw, Poland
[2] Minist Interior & Adm, Natl Med Inst, Dept Otolaryngol, Woloska 137, PL-02507 Warsaw, Poland
[3] Minist Interior & Adm, Natl Med Inst, Dept Hepatol, Woloska 137, PL-02507 Warsaw, Poland
[4] Inst Mother & Child Hlth, Dept Obstet & Gynecol, Kasprzaka 17a, PL-01211 Warsaw, Poland
[5] Minist Interior & Adm, Natl Med Inst, Dept Plast Surg, Woloska 137, PL-02507 Warsaw, Poland
[6] Inst Mother & Child Hlth, Ctr Reprod Hlth, Kasprzaka 17a, PL-01211 Warsaw, Poland
关键词
COVID-19; Liver damage; Pregnancy; Bile acids; SARS-CoV-2; SARS-COV-2; INFECTION; CHOLESTASIS;
D O I
10.1186/s12964-023-01285-z
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
IntroductionSARS-CoV-2 unsparingly impacts all areas of medicine. Pregnant women are particularly affected by the pandemic and COVID-19 related liver damage seems to be another threat to maternal and fetal health. The aim of this study is to define liver damage profile including bile acids serum levels in COVID-19 pregnant patients and to determine predictors of disease aggravation and poor obstetrics outcomes.MethodsThis study has been carried out in the Obstetrics and Gynecology Department, at the National Medical Institute in Warsaw, Poland between 01.02.2021 and 01.11.2022 The study cohort comprises 148 pregnant patients with COVID-19 and 102 pregnant controls who has been tested negative for SARS-CoV-2.ResultsCOVID-19 pregnant patients presented liver involvement at admission in 41,9%. Hepatotoxic damage accounted for 27 (19.85%), cholestatic type was diagnosed in 11 (8.09%) and mixed type of liver injury was presented in 19 (13.97%) of patients. Higher serum levels of AST, ALT, GGT, total bilirubin and bile acids as well as mixed type of liver injury at admission were correlated with severe form of an illness. AST and ALT above upper reference limit as well as hepatotoxic type of liver damage predisposed pregnant patients with COVID-19 to poor obstetrics outcomes.ConclusionHepatic damage in pregnant women with COVID-19 is a common, mild, transaminase-dominant, or mixed type of injury, and often correlates with elevated inflammatory markers. SARS-CoV-2 test should be performed as a part of differential diagnosis in elevated liver function tests. Although bile acids serum levels were commonly elevated they seems to be clinically irrelevant in terms of pregnancy outcomes.DaRpyovs-oA9XgYzu_a_v9Video AbstractConclusionHepatic damage in pregnant women with COVID-19 is a common, mild, transaminase-dominant, or mixed type of injury, and often correlates with elevated inflammatory markers. SARS-CoV-2 test should be performed as a part of differential diagnosis in elevated liver function tests. Although bile acids serum levels were commonly elevated they seems to be clinically irrelevant in terms of pregnancy outcomes.DaRpyovs-oA9XgYzu_a_v9Video Abstract
引用
收藏
页数:11
相关论文
共 50 条
  • [31] Hemostasis in pregnant women with COVID-19
    Ciavarella, Alessandro
    Erra, Roberta
    Abbattista, Maria
    Iurlaro, Enrico
    Boscolo-Anzoletti, Massimo
    Ossola, Manuela Wally
    Mosca, Fabio
    Ferrazzi, Enrico
    Peyvandi, Flora
    Martinelli, Ida
    INTERNATIONAL JOURNAL OF GYNECOLOGY & OBSTETRICS, 2021, 152 (02) : 268 - 269
  • [32] Pregnant Women and COVID-19 Pandemic
    Arabi, Maliheh
    Teymoordash, Somayyeh Noei
    TRAUMA MONTHLY, 2021, 26 (01) : 61 - 62
  • [33] Outcomes of COVID-19 among patients with liver disease
    Vujcic, Isidora
    WORLD JOURNAL OF GASTROENTEROLOGY, 2023, 29 (05) : 815 - 824
  • [34] COVID-19 Vaccination in Patients with Chronic Liver Disease
    Schinas, Georgios
    Polyzou, Eleni
    Mitropetrou, Fevronia
    Pazionis, Aristotelis
    Gogos, Charalambos
    Triantos, Christos
    Akinosoglou, Karolina
    VIRUSES-BASEL, 2022, 14 (12):
  • [35] Liver manifestations in COVID-19 patients: A review article
    Helou, Mariana
    Nasr, Janane
    El Osta, Nour
    Jabbour, Elsy
    Husni, Rola
    WORLD JOURNAL OF CLINICAL CASES, 2023, 11 (10) : 2189 - 2200
  • [36] Liver profile in COVID-19: a meta-analysis
    Abhishek Bansal
    Jang Bahadur Prasad
    Journal of Public Health, 2022, 30 : 253 - 258
  • [37] Liver and COVID-19: From care of patients with liver diseases to liver injury
    Gaspar, Rui
    Branco, Catarina Castelo
    Macedo, Guilherme
    WORLD JOURNAL OF HEPATOLOGY, 2021, 13 (10) : 1367 - 1377
  • [38] Liver Injury in Patients with COVID-19 without Underlying Liver Disease
    Pazgan-Simon, Monika
    Serafinska, Sylwia
    Kukla, Michal
    Kucharska, Marta
    Zuwala-Jagiello, Jolanta
    Buczynska, Iwona
    Zielinska, Kamila
    Simon, Krzysztof
    JOURNAL OF CLINICAL MEDICINE, 2022, 11 (02)
  • [39] Haematological profile of COVID-19 patients from a centre in Singapore
    Long, Valencia Shihuan
    Ngiam, Jinghao Nicholas
    Chew, Nicholas
    Tham, Sai Meng
    Lim, Zhen Yu
    Li, Tony
    Cen, Shuyun
    Annadurai, Jayagowtham K.
    Thant, Sandi Myo
    Tambyah, Paul Anantharajah
    Santosa, Amelia
    Teo, Winnie Z. Y.
    Yap, Eng Soo
    Cross, Gail Brenda
    Sia, Ching-Hui
    HEMATOLOGY, 2021, 26 (01) : 1007 - 1012
  • [40] Altered Lipid Profile in COVID-19 Patients and Metabolic Reprogramming
    Zhao, Tie
    Wang, Chunhui
    Duan, Biyan
    Yang, Peipei
    Wu, Jianguo
    Zhang, Qiwei
    FRONTIERS IN MICROBIOLOGY, 2022, 13